Understanding the Nutrition Facts Label, the Updated “Healthy” Claim, and Other Nutrition Claims

Drought exposure and the risk of sexual, emotional, and physical violence against adolescents in Zimbabwe, Mozambique, and Lesotho: an observational study ++

Drought exposure and the risk of sexual, emotional, and physical violence against adolescents in Zimbabwe, Mozambique, and Lesotho: an observational study Bothaina Eltigani, MBBS MSca Send email to bothaina.eltigani@spi.ox.ac.uk ∙ Roman Hoffmann, PhDb ∙ Prof Lucie Cluver, PhD https://www.thelancet.com/journals/lanplh/article/PIIS2542-5196(26)00021-5/fulltext?dgcid=hubspot_update_feature_updatealerts_lanplh&utm_campaign=update-lanplh&utm_medium=email&_hsenc=p2ANqtz-_7W6jDY9UM0WrNHb4uFco-t6owxYfT8CC7xN9u-H2EQY3W0VpiEkEEjWTmMHN9cpnzJfp2htCefeGusHsDWK9jkNVMWQ&_hsmi=424093836&utm_content=423511253&utm_source=hs_email The burden of El Niño–Southern Oscillation-related dengue attributable to anthropogenic climate change: a multicountry modelling study Guoao Li, MSa,b ∙ Peng Lu, PhDc ∙ Philip Weinstein, PhDd,e ∙ Aleš Urban, PhDf,g ∙ Shilu Tong, PhDh,i ∙ Niilo Ryti, PhDj,k,l ∙ et al. https://www.thelancet.com/journals/lanplh/article/PIIS2542-5196(26)00027-6/fulltext?dgcid=hubspot_update_feature_updatealerts_lanplh&utm_campaign=update-lanplh&utm_medium=email&_hsenc=p2ANqtz-_HGjcVx7WQ1VgDBQyZb6PkoAeQjJBTwf6JyjWGnQCCb9Se-hwvCMn77EBFE_TctLVJFQHV9h1L8K4-TSCUYn9ON4a2Lg&_hsmi=424093836&utm_content=423511253&utm_source=hs_email

Physiological and biological response to heat exposure in pregnancy: a systematic review and meta-analysis ++...

Physiological and biological response to heat exposure in pregnancy: a systematic review and meta-analysis Ana Bonell, MBChB PhDa,b,∗ Send email to ana.bonell@lshtm.ac.uk ∙ Asma Abdul Malik Qureshi, MBChBc,∗ ∙ Prof Andreas D Flouris, PhDd ∙ Lydia Tsoutsoubi, PhDd ∙ Prof Amanda N Sferruzzi-Perri, PhDe ∙ Jai K Das, MBChB PhDc,g ∙ et al. https://www.thelancet.com/journals/lanplh/article/PIIS2542-5196(26)00004-5/fulltext?dgcid=hubspot_update_feature_updatealerts_lanplh&utm_campaign=update-lanplh&utm_medium=email&_hsenc=p2ANqtz-9jeIMAC2lIM4HvGlIGJFHwaID21L-ac697co2nOgG_5LJZUFfHf7juCeyiEq7SCUs1RPhdSUWdMicx064l6hC0bpkuTw&_hsmi=424093836&utm_content=423511253&utm_source=hs_email Apr 2026 Volume 10Number 4 https://www.thelancet.com/journals/lanplh/issue/vol10no4/PIIS2542-5196(26)X2004-6

Bearing metabolism in mind: towards integrated care The Lancet Diabetes & Endocrinology ++... ++

Bearing metabolism in mind: towards integrated care The Lancet Diabetes & Endocrinology https://www.thelancet.com/journals/landia/article/PIIS2213-8587(26)00137-3/fulltext?dgcid=raven_jbs_etoc_email Jul 2026 Volume 14Number 7p533-616, e10 https://www.thelancet.com/journals/landia/issue/vol14no7/PIIS2213-8587(26)X2005-8 Multi-ancestry polygenic risk scores for the prediction of type 2 diabetes and complications in diverse ancestries Alicia Huerta-Chagoya, PhDa,b,c,* ∙ Joohyun Kim, PhDd,* ∙ Ravi Mandla, BAa,b,c,e,† ∙ Yingchang Lu, PhDd,† ∙ Ken Suzuki, PhDf,g,h,† ∙ Lauren E Petty, PhDd,† ∙ et al. https://www.thelancet.com/journals/landia/article/PIIS2213-8587(25)00405-X/fulltext?dgcid=raven_jbs_etoc_feature_landia Effects of a 6-week subcutaneous infusion of native GIP alone or as add-on to semaglutide in people with type 2 diabetes: a single-centre, double-blind, parallel-group, randomised, placebo-controlled trial Mads M Helsted, MDa ∙ Christiane Fonnesbech-Wulff, MBBSa ∙ Nina L Schaltz, MBBSa ∙ Ingrid W Lund, MBBSa ∙ Julie L Forman, PhDb ∙ Casper K Nielsen, PhDa ∙ et al. https://www.thelancet.com/journals/landia/article/PIIS2213-8587(26)00075-6/abstract?dgcid=raven_jbs_etoc_feature_landia

Mastocytosis: before, during and after diagnosis 17 June 2026 Written by Emma Bishop, RARE Revolution

https://rarerevolutionmagazine.com/mastocytosis-before-during-and-after-diagnosis/ Living with mastocytosis means navigating unpredictable, sometimes life‑threatening reactions alongside chronic pain, fatigue and fear. In April 2026, RARE Revolution hosted our 25th RARE Rev-inar. Sponsored by Blueprint Medicines, a Sanofi company, this discussion sees patient advocate Shawna Hull share her own personal journey with mastocystosis, and physician-scientist Dr Polina Pyatilova discuss the complexities of the disease and how a strong patient-doctor relationship allows for optimal care Written by Emma Bishop, RARE Revolution

Optimizing Outcomes With Radiopharmaceuticals in mCRPC Care: From Evidence to Execution Authors: Joe O’Sullivan, PhD, MD, BAO, BCH, FRCR, FFRRCSI, FRCPI; Irene Burger, MD; Elena Castro, MD, PhD; Bertrand Tombal, MD, PhD

https://www.medscape.org/viewarticle/1003032?uac=148436CN&src=mkmcmr_driv_stan_mscpedu_260616-OUS-HONC-1003032-cta

Blinatumomab Outperforms Chemotherapy in High-Risk B-ALL Randy Dotinga June 17, 2026 ++++++

Blinatumomab Outperforms Chemotherapy in High-Risk B-ALL Randy Dotinga https://www.medscape.com/viewarticle/blinatumomab-outperforms-chemotherapy-high-risk-b-all-2026a1000kfo June 17, 2026 Replacing two blocks of chemotherapy with two blocks of the bispecific antibody blinatumomab significantly improved event-free survival in children with high-risk B-cell acute lymphoblastic leukemia (B-ALL), according to findings from the randomized, phase 3 AIEOP-BFM ALL 2017 trial. GLP-1s Tied to Lower Cancer Risk in Patients With Obesity Will Pass https://www.medscape.com/viewarticle/glp-1s-tied-lower-cancer-risk-patients-obesity-2026a1000kg6 June 17, 2026 Individuals with obesity without diabetes taking GLP-1 receptor agonists (RAs) may have a reduced risk for certain cancers, a new study suggests. Is There a Role for Stimulants in Beating Cancer Fatigue? Ernie Mundell https://www.medscape.com/viewarticle/there-role-stimulants-beating-cancer-fatigue-2026a1000ked June 17, 2026 Current guidelines on treating cancer fatigue suggest that stimulants like methylphenidate be used sparingly if at all. But a recent meta-analysis supports a bigger role for the medications, possibly as a bridge to nondrug therapies. Water Ablation Therapy Shows Early Promise for Prostate Cancer Edited by Madhurima Roy https://www.medscape.com/viewarticle/water-ablation-therapy-shows-early-promise-prostate-cancer-2026a1000kdi June 17, 2026 Transurethral ablation of Gleason grade group 2 (GG2) lesions using water vapor therapy cleared the area of prostate cancer in 75% of men and 91% had no GG2 or higher-grade cancer remaining at 6 months. Combination Treatment May Improve Multiple Myeloma Outcomes Cristina Ferrario https://www.medscape.com/viewarticle/combination-treatment-may-improve-multiple-myeloma-outcomes-2026a1000kda Medscape Europe logo June 17, 2026 STOCKHOLM — Patients with relapsed or refractory multiple myeloma (RRMM) benefit from teclistamab plus daratumumab (Tec-Dara), irrespective of cytogenetic and functional risk status, according to research presented at the European Hematology Association (EHA) 2026 Congress. Pre-Resection MRI May Incorrectly Stage Large Rectal Polyps Edited by Mandeep Singh Rawat https://www.medscape.com/viewarticle/pre-resection-mri-may-incorrectly-stage-large-rectal-polyps-2026a1000ke3 June 17, 2026 In 44 patients with large rectal polyps referred for endoscopic resection, pelvic MRI overstaged tumor depth (T-stage) and nodal status (N-stage) in 38.6% and 2.3% of cases, respectively, potentially leading to unnecessary surgery. Endoscopic resection provided definitive histologic staging and was an effective organ-sparing treatment approach, with no recurrences observed during follow-up.